Bank Of America Corp Abb Vie Inc. Put Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $737,280 - $896,985	-4,500 Reduced 1.08%	412,100 $81.4 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $5.93 Million - $6.92 Million	-38,300 Reduced 8.42%	416,600 $71.5 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $43.9 Million - $50 Million	-274,400 Reduced 37.63%	454,900 $82.8 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $36.4 Million - $41 Million	264,600 Added 56.94%	729,300 $113 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $25.5 Million - $31.7 Million	192,300 Added 70.59%	464,700 $62.6 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $24.4 Million - $28.1 Million	-169,000 Reduced 38.29%	272,400 $43.4 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $12.7 Million - $15.3 Million	92,100 Added 26.37%	441,400 $71.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $6.32 Million - $7.25 Million	47,100 Added 15.59%	349,300 $46.9 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $467,908 - $594,864	-3,400 Reduced 1.11%	302,200 $46.3 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $15.5 Million - $19.3 Million	-117,800 Reduced 27.82%	305,600 $49.5 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $2.69 Million - $3.4 Million	-25,000 Reduced 5.58%	423,400 $57.3 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $17.6 Million - $20 Million	-165,600 Reduced 26.97%	448,400 $48.4 Million
Q2 2021 Sep 13, 2021	BUY	$105.21 - $117.21 $64.6 Million - $72 Million	614,000 New	614,000 $69.2 Million

3,837

1.25B

15.7M

11.3M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.